Maebius Quoted in Bloomberg Law About Challenges of Patent Pooling
06 May 2020
Bloomberg Law
Partner Steve Maebius was quoted in the Bloomberg Law article, “Pooling Patents to Speed Virus Treatments More Logical Than Easy,” about the challenges in pooling patents as a way to help address a health crisis. The ideas has been resurrected in light of the current pandemic, and although it makes logical sense, it’s not easy to effectuate.
“What the pandemic did was it galvanized all these different entities to look at a very specific medical problem that arose with incredible urgency and became an acute problem for the entire world,” Maebius said.
People
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."